Biochemical and Biophysical Research Communications, Vol.534, 702-706, 2021
Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic beta-cells
There have been several clinical reports of transient postoperative hyperglycemia in patients with insulinoma, but the effect of insulinoma on normal beta-cells has not been investigated. We examined the glucose transporter 2 (GLUT2) and glucagon-like peptide 1 receptor (GLPIR) expression in normal pancreatic beta-cells of five patients with insulinoma and five patients with normal glucose tolerance (NGT) as controls. The positive rate of GLUT2-or GLP1R-positive islets in the nontumor area was calculated by the ratio with the analyzed islets. For functional in vitro analyses, q-PCR and Western blotting were performed after insulin loading on MIN6 cells. The expression rates of both GLUT2 and GLP1R were significantly lower in nontumor area islets of insulinoma patients than in patients with NGT (GLUT2: 31.6 +/- 15.3% vs 95.9 +/- 6.7%, p < 0.01, GLP1R: 66.8 +/- 15.0% vs 96.7 +/- 5.0%, p < 0.01). Exposure of MIN6 cells to high concentrations of insulin resulted in a significant decrease in GLUT2 protein for 12 h and GLPIR protein for 24 h (GLUT2; 1.00 +/- 0.079 vs 0.81 +/- 0.04. p = 0.02, GLP1R; 1.00 +/- 0.10 vs 0.50 +/- 0.24, p = 0.03) but not in those mRNAs. Our findings show that insulinoma is associated with the downregulation of GLUT2 and GLPIR expression in nontumor area islets. These phenomena may be caused by high levels of insulin. (C) 2020 Elsevier Inc. All rights reserved.